US Stock MarketDetailed Quotes

LYRA Lyra Therapeutics

Watchlist
  • 0.522
  • -3.509-87.06%
Close May 6 16:00 ET
  • 0.474
  • -0.047-9.09%
Pre 05:36 ET
31.79MMarket Cap-413P/E (TTM)

About Lyra Therapeutics Company

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.

Company Profile

SymbolLYRA
Company NameLyra Therapeutics
Listing DateMay 1, 2020
Issue Price16.00
Founded2005
CEODr. Maria Palasis, PhD
MarketNASDAQ
Employees145
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address480 Arsenal Way
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-393-4600
Websitehttp://www.lyratherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Maria Palasis, PhD
  • Director, President and Chief Executive Officer
  • 1.79M
  • Jason Cavalier
  • Chief Financial Officer, Treasurer and Principal Accounting Officer
  • --
  • Dr. Richard Nieman
  • Chief Medical Officer
  • --
  • Dr. John E. Bishop, PhD
  • Chief Technology Officer
  • 1.03M
  • Dr. Harlan W. Waksal,M.D.
  • Executive Chairman of the Board
  • 625.06K
  • James R. Tobin
  • Lead Independent Director
  • 152.31K
  • W. Bradford Smith
  • Independent Director
  • 123.81K
  • Dr. Nancy L. Snyderman, F.A.C.S.,M.D.
  • Independent Director
  • 109.06K
  • C. Ann Merrifield
  • Independent Director
  • 113.06K
  • Konstantin Poukalov
  • Independent Director
  • 99.81K
  • Michael Altman, C.F.A.
  • Independent Director
  • 99.81K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg